← FDA Drug Approvals (Drugs@FDA)
TELMISARTAN AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2019-03-04
Drug application
- FDA Application #
ANDA202544- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Generic name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Active ingredients
- HYDROCHLOROTHIAZIDE; TELMISARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLENMARK PHARMS LTD
- Manufacturer
- AvKARE
- First approval
- 2019-03-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown